Resident Physician - PGY 1
If you are a patient, please do not contact a physician by email without their prior expressed consent due to confidentiality concerns.
Resident Physician - PGY 1
If you are a patient, please do not contact a physician by email without their prior expressed consent due to confidentiality concerns.
UCSF OB/GYN&RS Residency Program
490 Illinois Street
10th Floor, Box 0132
San Francisco, CA 94143
Location | Office Phone | Fax |
---|---|---|
Mission Bay | (415) 476 - 5192 | (415) 476 - 1811 |
Mount Zion | (415) 353 - 9240 | (415) 353 - 9509 |
San Francisco General Hospital | (628) 206 - 3061 | (628) 206 - 3112 |
Research/Clinical Interests: Reproductive justice, non-medical birth workers, alternative models of pregnancy and postpartum care delivery, accessibility and attitudes towards abortion services for those with fetal genetic diagnoses, prenatal testing technologies, immunology of the maternal-fetal interface, in vivo technology development for somatic gene editing and targeted delivery, entrepreneurship in femtech and biotech, pedagogy in medical education, history of obstetrics and gynecology.
Year |
Institution | Degree | Field of Study |
---|---|---|---|
current | University of California, San Francisco | Residency | Obstetrics, Gynecology and Reproductive Sciences |
2023 | University of Maryland, Baltimore School of Medicine | MD | Medicine |
2021 | University of Maryland, Baltimore Graduate School | PhD | Molecular Microbiology and Immunology |
2013 | Johns Hopkins Bloomberg School of Public Health | ScM | Reproductive and Cancer Biology |
2010 | University of California, Berkeley College of Letters and Sciences | BA | Development Studies, Molecular and Cell Biology |
Year | |
---|---|
2021 - 2024 | Graduate Research Assistant; Evaluating Pathogen-Reduction Technology to Standard-of-Care for Platelet Products During Surgeries Requiring Cardiopulmonary Bypass; University of Maryland, Baltimore |
2018-2021 | Graduate Research Assistant: Modulating the Immune Response with Nanotechnology; University of Maryland, Baltimore |
2016 - 2018 | Graduate Research Assistant: TLR Signaling - Investigation of the Immunomodulatory Potential of IRAKs in Immunotherapy-Resistant Cancer; University of Maryland, Baltimore |
2013-2014 | Clinical Research Coordinator: Hepatitis Testing and Linkage to Care (HepTLC) Study, Johns Hopkins University |
2012-2013 | Graduate Research Assistant: Colorectal Infection, Inflammation, and Tumorigenesis; Johns Hopkins University |
Year | Major Honors |
---|---|
2014 - 2023 | NIH Medical Scientist Training Program Trainee; University of Maryland, Baltimore |
2022 - 2023 | Global Health Scholar; University of Maryland Center for International Health, Education, and Biosecurity (Ciheb) |
2016 - 2021 | NIH Initiative for Maximizing Student Development (IMSD) Meyerhoff Graduate Fellow; University of Maryland, Baltimore and University of Baltimore, Baltimore County |
2021-2022 | Collaborative Teaching Fellow at Morgan State University; Johns Hopkins University Center for Excellence and Innovation |
2021 | Diversity Award, 36th Annual National MD-PhD Student Conference |
2019 - 2021 | NIH/NIAID T32 Pre-doctoral Trainee "Training Program in Signaling Pathways in Innate Immunity"; University of Maryland, Baltimore |
2019-2020 | President's Entrepreneurial Fellow; University of Maryland, Baltimore |
2019 | Shock Society Diversity Enhancement Award, 42nd Annual Conference on Shock |
2018 - 2019 | NIH/NHLBI T32 Pre-doctoral Trainee "Interdisciplinary Training Program in Cardiovascular Disease"; University of Maryland, Baltimore |
Scotland BL, Cottingham AL, LASOLA JJ, Pearson RM. Protein-polymer Bioconjugate Nanoparticles to Investigate Innate and Antigen-specific CD4 T-cell Responses. Immunology 2023, Washington, DC, 11-15 May 2023.
Truong N, Dharmaraj S, Cottingham A, Shaw J, LASOLA J, Scotland B, Pearson RM. Poly(lactic acid)-based immunomodulatory nanoparticles promote survival in a polymicrobial mouse model of sepsis. Immunology 2023, Washington, DC, 11-15 May 2023.
LASOLA JJM, Martinez-Hernandez A, Henderson RA, Fontaine MJ. Improving efficacy and safety of pathogen inactivation strategies for platelet transfusion. CERSI 2023 Innovations in Regulatory Science Summit, University of California San Francisco, San Francisco, CA 8 January 2023.
Cottingham A, LASOLA JJM, Scotland BL, Truong N, Hong CC, Shapiro P, Pearson RM. Poly(lactic acid) nanoparticle modulation of macrophage inflammatory responses. Society for Biomaterials 2022 Annual Meeting and Exposition, Baltimore, MD, 27-30 April 2022.
LASOLA JJM, Kamdem H, McDaniel M, Pearson R. Innate immune cell modulation using cargo-less nanoparticles to ameliorate severe inflammation. Immunology 2020, Honolulu, HI, 8-12 May 2020. Canceled due to the COVID-19 pandemic.
LASOLA J, Pearson R. Physical and biological mechanisms of nanoparticle-induced inhibition of Toll-like receptor activation. 2019 Biomedical Engineering Society Annual Meeting, Philadelphia, PA, 16-19 Oct 2019.
Zhang M, Chakraborty A, LASOLA J, Pearson R, Szeto G. Engineered lipid and PLGA-based antigen bioconjugates for cellular vaccines. 2019 Biomedical Engineering Society Annual Meeting, Philadelphia, PA, 16-19 Oct 2019.
LASOLA JJM, Kamdem H, McDaniel M, Pearson RM. Evaluation of innate immune cell reprogramming using cargo-less nanoparticles to ameliorate severe inflammation. 42nd Annual Conference on Shock, Coronado, CA, 8-11 Jun 2019.
LASOLA JJM, Geng D, Davila E. Immunomodulation of the tumor microenvironment with interleukin-1 receptor-associated kinases (IRAKs). IMSD Meyerhoff Graduate Program: Celebrating 21 years, 100+ PhDs, and a Culture of Excellence Celebration; University of Maryland, Baltimore County, Catonsville, MD, 10 Aug 2018.
LASOLA JJM, Geng D, Davila E. Interrogating the role of the IRAKs in melanoma tumor growth. University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center 9th Annual Cancer Biology Retreat, Baltimore, MD 30 April 2018.
LASOLA JJM, Geng D, Davila E. Immunomodulation of the tumor microenvironment with interleukin-1 receptor-associated kinases (IRAKs). 2018 PROMISE Maryland’s Alliance for Graduate Education and the Professorate Research Symposium and Professional Development Conference, College Park, MD, 16 Feb 2018.
Geng D, LASOLA JJM, Ciavattone N, Wang L, Davila E. IRAK-M has a role as a tumor suppressor in human melanoma. University of Maryland Cancer Center Research and Cancer Network Day, Baltimore, MD, 19 Sep 2017.
LASOLA JJM, Geng D, Shrestha R, Davila E. IRAK-4 signaling in melanoma contributes to reduced expression of inflammatory factors in vitro while contributing to tumor growth in vivo. American Association for Cancer Research Conference on Tumor Immunology and Immunotherapy, Boston, MA, 20-23 Oct 2016.
Falade-Nwulia O, Irvin R, McAdams-Mahmood A, Mehta S, LASOLA J, Baker D, Eppel A, Chaulk P, Page K, Sulkowski M, Thomas D. Senior Center Based Hepatitis C Screening in Baltimore. The Liver Meeting: 65th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, MA, 7-8 Nov 2014.
LASOLA JJ, Ezelle H, Hassel BA. The Impact of Enteropathogenic E. coli Type III Secretion System Effectors on RNase-L Activity. 37th Annual Medical Student Research Day, University of Maryland School of Medicine, Baltimore, MD, 18 Sep 2014.
Falade-Nwulia O, Mehta S, Sulkowski M, LASOLA J, Ghanem K, Chaulk P, Thomas D. Impact of Rapid Hepatitis C Testing on Receipt of Hepatitis C Results in a Public STD Clinic. 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 3-6 Mar 2014.
Truong N, Cottingham A, Shaw J, Dmarmaraj S, LASOLA JJM, Goodis C, Fletcher S, Pearson R. Nanoparticle-based immunotherapy as a multimodal approach to attenuate severe inflammation in sepsis. Society for Biomaterials 2022 Annual Meeting and Exposition, Baltimore, MD, 27-30 April 2022.
LASOLA JJM, Cottingham A, Scotland BL, Hong CC, Shapiro P, Pearson RM. Understanding the mechanistic activity of immunomodulatory nanoparticles to ameliorate severe inflammation. Controlled Release Society 2021 Virtual Annual Meeting, 25-29 July 2021.
LASOLA JJM, Cottingham C, Scotland BL, Hong CC, Shapiro P, Pearson RM. Understanding the cellular mechanisms driving the immunomodulatory activity of cargo-less nanoparticles. 36th Annual National MD-PhD Student Conference (Virtual), 09-11 Jul 2021.
Pearson R, Chakraborty A, LASOLA J, Truong N. Serum-independent non-viral transfection of immune cells. 2020 Biomedical Engineering Society Virtual Annual Meeting, 14-17 Oct 2020.
LASOLA JJM, Kamdem H, McDaniel M, Pearson RM. Evaluation of innate immune cell reprogramming using cargo-less nanoparticles to ameliorate severe inflammation. 42nd Annual Conference on Shock, Coronado, CA, 8-11 Jun 2019.
LASOLA JJ, Noh JH, Gorospe M. Cellular Senescence Alters the Mitochondria-Associated microRNA Profile of WI-38 Cells. 38th Annual Medical Student Research Day, University of Maryland School of Medicine, Baltimore, MD, 17 Sep 2015.
Falade-Nwulia O, Mehta S, LASOLA J, Chaulk CP, Ghanem KG, Page K, Thomas D, Sulkowski M. Sexually Transmitted Diseases Clinic Based Hepatitis C Testing and Linkage to Care. IDWeek 2014, Philadelphia, PA, 8-12 Oct 2014.
Fontaine MJ, LASOLA JJM, Martinez-Hernandez A, Marshall JN, Bentsen S, Lokhandwala P, Tanaka K, Villa C, Henderson RA. 2024. Improving efficacy and safety of pathogen inactivation strategies for platelet transfusion. Transfusion. In preparation.
Truong N, Cottingham A, Dharmaraj S, Shaw J, LASOLA J, Goodis C, Fletcher S, Pearson R. 2024. Multimodal nanoparticle-containing modified suberoylanilide hydroxamic acid polymer conjugates to mitigate immune dysfunction in severe inflammation. Bioeng Transl Med 9, e10611. DOI: 10.1002/btm2.10611.
Scotland BL, Shaw JR, Dharmaraj S, Caprio N, Cottingham AL, LASOLA J, Sung JJ, Pearson R. 2023. Cell and biomaterial delivery strategies to induce immune tolerance. Adv Drug Deliv Rev 203, 115141. DOI: 10.1016/j.addr.2023.115141.
Scotland B, Cottingham A, LASOLA JJ, Hoag S, Pearson R. 2023. Protein-polymer conjugate nanoparticles to elucidate dendritic and antigen-specific CD4+ T cell responses for immunotherapy development. ACS Appl Polym Mater 5, 8794-8807. DOI: 10.1021/acsapm.3c00548.
Fontaine MJ, LASOLA JJM, Henderson RA. 2022. Perioperative Platelet Transfusion: Not All Platelet Products Are Created Equal. Current Anesthesiology Reports 12, 320-328. DOI: 10.1007/s40140-022-00522-4.
LASOLA JJM, Cottingham AL, Scotland BL, Truong N, Hong CC, Shapiro P, Pearson RM. 2021. Immunomodulatory Nanoparticles Mitigate Macrophage Inflammation via Inhibition of PAMP Interactions and Lactate-Mediated Functional Reprogramming of NF-κB and p38 MAPK. Pharmaceutics 13, 1841. DOI: 10.3390/pharmaceutics13111841. PMID: 34834256.
Chakraborty A, LASOLA JJ, Truong N, Pearson RM. 2020. Serum-independent non-viral gene delivery to innate and adaptive immune cells using immunoplexes. ACS Applied Bio Materials 3, 6263-6272. DOI: 10.1021/acsabm.0c00761. PMID: PMC8486289.
LASOLA JJM, Kamdem H, McDaniel MW, Pearson RM. 2020. Biomaterial-driven immunomodulation: Cell biology-based strategies to mitigate severe inflammation and sepsis. Frontiers in Immunology 11, 1726. DOI: 10.3389/fimmu.2020.01726. PMID: 32849612.
Geng D, Ciavattone NG, LASOLA JJ, Shrestha R, Sanchez A, Guo J, Vlk A, Younis R, Wang L, Brown A, Zhang Y, Velasco-Gonzalez C, Sanchez A, Tan A-C, Davila E. 2020. Induction of IRAK-M in melanoma induces caspase-3 dependent apoptosis by reducing TRAF6 and calpastatin levels. Communications Biology 3, 306. DOI: 10.1038/s42003-020-1033-y. PMID: 32533049.
Kaczanowska S, Joseph AM, Guo J, Tsai A, LASOLA JJM, Younger K, Zhang Y, Velasco Gonzales C, Davila E. 2017. A synthetic CD8α:MyD88 co-receptor enhances cytotoxic T cell responses to weakly immunogenic and lowly expressed tumor antigen. Cancer Research 77, 7049-7058. DOI: 10.1158/0008-5472.CAN-17-0653. PMID: 29055013.
Falade-Nwulia O, Mehta SH, LASOLA J, Latkin C, Niculescu A, O’Connor C, Chaulk P, Ghanem K, Page KR, Sulkowski MS, Thomas DL. 2016. Public health clinic-based hepatitis C testing and linkage to care in Baltimore. Journal of Viral Hepatitis 23, 366-74. DOI: 10.1111/jvh.12507. PMID: 26840570.
Falade-Nwulia O, Irvin R, McAdams-Mahmoud A, Mehta SH, Niculescu A, LASOLA J, Baker D, Eppel A, Chaulk P, Page KR, Sulkowski M, Thomas D. 2016. Senior Center-Based Hepatitis C Screening in Baltimore. Open Forum Infectious Disease 3: ofv217. DOI: 10.1093/ofid/ofv217. PMID: 26885546.
LASOLA JJM, Hodgson A, Sun X, Wan F. 2014. The PARP1/ARTD1-Mediated Poly-ADP-Ribosylation and DNA Damage Repair in B-Cell Diversification. Antibodies 3, 37-55. DOI: 10.3390/antib3010037.
O’Grady PM, Lapoint RT, Bonacum J, LASOLA J, Owen E, Wu Y, DeSalle R. 2011. Phylogenetic and ecological relationships of the Hawaiian Drosophila inferred by mitochondrial DNA analysis. Molecular Phylogenetics and Evolution 58, 255-266. DOI: 10.1016/j.ympev.2010.11.022. PMID: 21144904.
Interviewee, “OB-GYN Training and Practice in Dobbs’ Shadow” by Annalies Winny, Johns Hopkins Bloomberg Public Health Magazine, Spring/Summer 2024 (May 9, 2024)
ACOG District IV Lobbyist, 2024 ACOG Congressional Leadership Conference (March 3-5, 2024)
Lobbyist, 2024 Maryland ACOG Advocacy Day (January 26, 2024)
Panelist for University of Maryland, US Department of Health and Human Services Secretary Becerra’s Reproductive Health Care Series (January 19, 2024)
Interviewee, “Without federal subsidies, childcare providers contemplate raising rates, and parents are worried” by Stephanie Hughes, NPR Marketplace Morning Report (November 20, 2023)
All-Options Talkline Advocate, M+A Hotline Logistics Volunteer, Baltimore Doula Project Leadership Circle, Council of Young Filipinx Americans in Medicine Resident Special Interest Chair